An observational study in Breast Cancer, sponsored by Northwestern University. Recruiting at 1 site in United States. Open to female participants. Per ClinicalTrials.gov, last updated 2025-10-20.
Sponsored by Northwestern University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 64 studies in Breast Neoplasms by Northwestern University — 4 open to participants now, 6 under way, 1 of them phase 3. Breast Neoplasms · Northwestern University.
Among the 64 studies in Breast Neoplasms by Northwestern University, this one is one of 2 that started in 2001, is one of 7 observational ones, and was the 22nd registered.
14,855 studies on the registry are indexed under Breast Neoplasms; 3,321 are open to participants now.
Browse Breast Neoplasms studies →4 of the 64 studies in Breast Neoplasms by Northwestern University are open now, in 2 countries. Recruiting first, the newest first:
Northwestern University · Sites in Nigeria
Ages 18+
Northwestern University · Sites in United States
Ages 18+
Northwestern University · Sites in United States
Ages 18+ · Women only
By country, each count listing its studies:
Of the 2,403 Breast Neoplasms studies recruiting now, 1,574 (66%) set no upper age limit and 591 (25%) stop at 75 or younger; 103 take children under 18; 215 take healthy volunteers.
This study: female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
64 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 14 · Phase 2 24 · Phase 3 3
First in 1998; this study’s year is marked. 2 started in 2001.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 10,000 is above the median of 184 across 3,239 observational studies indexed under Breast Neoplasms.
Median enrollment 31 across the 50 interventional studies, 79 across the 7 observational. Of the 47 that completed or were terminated, 15 (32%) have results posted.
This tab as a report to print or save as PDF → With an account.
Northwestern University is the lead sponsor of 1,424 studies on the registry; 199 are open to participants now.
Of its 105 completed or terminated interventional studies of FDA-regulated products, 78 (74%) have results posted.
2 of the studies in Breast Neoplasms by Northwestern University that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05703178Phase 3Northwestern UniversityWeb-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia | 2026-11-30 |
| NCT05931874Northwestern UniversityOptimizing a mHealth Physical Activity Intervention With Mindful Awareness Lessons in Breast Cancer Survivors | 2027-08-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 64 studies in Breast Neoplasms by Northwestern University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
RATIONALE: Collecting and storing samples of tumor tissue from patients with breast cancer to study in the laboratory may help doctors learn more about cancer.
PURPOSE: This phase I study is collecting tissue samples for future research from women undergoing surgery for breast cancer.
OBJECTIVES:
Primary
Secondary
OUTLINE: Tumor tissue is collected and analyzed to create microarrays by tumor type for future research studies.
PROJECTED ACCRUAL: A total of 1,250 patients will be accrued for this study.
Women undergoing biopsy or surgical procedures for the diagnosis, treatment, or prevention of breast cancer.
DISEASE CHARACTERISTICS:
Collect human breast tissues and associated clinical-pathologic data
Time frame: At time of diagnosis, surgery, and throughout standard care and clinical follow-up.
The record gives a start of Aug 2001, a primary completion of Jan 2026 and a completion of Jan 2026. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.